NCT01103336 - Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study) | Biotech Hunter

Enrollment

173

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Chronic Renal Failure

Interventions

DRUG

pretreatment with intravenous nicorandil vs. placebo before coronary angiography

"* Nicorandil group: Pretreatment with intravenous Nicorandil (Sigmart for injection, Choongwae Pharma, Seoul) 12 mg in 0.9% saline 100 ml over 2 hours starting from 1 hour prior to coronary angiography~* Control group: Pretreatment with intravenous 0.9% saline 100 ml over 2 hours starting from 1 hour prior to coronary angiography"

Trial Locations (1)

120-752

Severance Hospital, Seoul